Results 1 to 10 of about 5,367 (160)

Dequalinium Chloride Effectively Disrupts Bacterial Vaginosis (BV) Gardnerella spp. Biofilms. [PDF]

Pathogens, 2021
Bacterial vaginosis (BV) is the most frequent vaginal infection worldwide. It is caused by the overgrowth of anaerobic vaginal pathogens such as Gardnerella spp. BV has been associated with the occurrence of dense multispecies biofilms on the vaginal mucosa. Treatment of biofilm-associated infections such as BV is challenging.
Gaspar C, Rolo J, Cerca N, Palmeira-de-Oliveira R, Martinez-de-Oliveira J, Palmeira-de-Oliveira A.   +5 more
europepmc   +7 more sources

Getting Everyone on Board to Break the Cycle of Bacterial Vaginosis (BV) Recurrence: A Qualitative Study of Partner Treatment for BV. [PDF]

Patient
Bacterial vaginosis (BV) is a common condition that affects the sexual wellbeing of women and other people with a vagina. Recurrence following individual treatment is frequent and exerts a cumulative burden over time. Researchers at the Melbourne Sexual Health Center have recently completed the first successful trial of male partner treatment (MPT) for
King AJ, Phillips TR, Plummer EL, Wild N, Fairley CK, Chow EPF, Vodstrcil LA, Bradshaw CS.   +7 more
europepmc   +3 more sources

Effect of Bacterial Vaginosis (BV)-HIV-1 Co-existence on Maternal and Infant Health: A Secondary Data Analysis. [PDF]

Front Pediatr, 2021
Background: The lactobacillus-rich microbiome forms a defense system against infections. Babies are born sterile and acquire their microbiome from exposure to the mothers' vaginal and rectal microbiota. Bacterial vaginosis (BV), which is characterized by a deficit of the Lactobacilli genera, may predispose women
Mwenda N, Nduati R, Kosgey M, Kerich G.
europepmc   +6 more sources

Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. [PDF]

Anaerobe, 2017
Secnidazole, a 5-nitroimidazole with a longer half-life, is structurally related to metronidazole and tinidazole. For treatment of bacterial vaginosis (BV), secnidazole is a suitable single-dose oral drug having a longer serum half-life than metronidazole.
Petrina MAB, Cosentino LA, Rabe LK, Hillier SL.   +3 more
europepmc   +4 more sources

IgA coating of vaginal bacteria is reduced in the setting of bacterial vaginosis (BV) and preferentially targets BV-associated species. [PDF]

Infect Immun
ABSTRACT Immunoglobulin (Ig) bacterial coating has been described in the gastrointestinal tract and linked to inflammatory bowel disease; however, little is known about Ig coating of vaginal bacteria and whether it plays a role in vaginal health including bacterial vaginosis (BV).
Murphy K, Gromisch M, Srinivasan S, Wang T, Wood L, Proll S, Liu C, Fiedler T, Valint DJ, Fredricks DN, Keller MJ, Herold BC.   +11 more
europepmc   +3 more sources

Bacterial Vaginosis (BV) and Vaginal Microbiome Disorders in Women Suffering from Polycystic Ovary Syndrome (PCOS). [PDF]

Diagnostics (Basel)
Introduction: Polycystic ovary syndrome (PCOS) is a multifactorial, heterogeneous endocrine and metabolic disorder in women. Due to its association with the menstrual cycle and fertility disorders, the importance of this problem is emphasized especially in patients of reproductive age.
Chudzicka-Strugała I, Gołębiewska I, Banaszewska B, Trzciński M, Brudecki G, Elamin W, Zwoździak B.   +6 more
europepmc   +4 more sources

Bacterial vaginosis (BV) and Trichomonas vaginalis (TV) co-infection, and bacterial antibiogram profile of pregnant women studied in Lagos, Nigeria. [PDF]

BMC Womens Health
Abstract Aim This study was undertaken to determine the prevalence of Bacterial Vaginosis (BV), Trichomonas Vaginalis (TV) co-infection, and the antibacterial sensitivity profile of bacterial isolates. Methods The study was a cross-sectional study of 232 pregnant women on a ...
Enwuru CA, Aiyedobgon AS, Ajayi MB, Osuolale KA.   +3 more
europepmc   +4 more sources

Prevalence, antimicrobial resistance, and associated factors of bacterial vaginosis and aerobic vaginitis among women suspected of STIs in Bahir Dar, Ethiopia [PDF]

BMC Women's Health
Background Bacterial vaginosis (BV) and aerobic vaginitis (AV) are characterized by an imbalance of vaginal microbiome, becomes a serious public health crisis especially in low and middle income country.
Addisu Gizat, Tewachew Awoke, Michael Getie, Tsehaynesh Gebreyesus, Alem Tsega, Wudu Tafere, Seid Ali, Asrat Mesele, Kebede Getachew, Desalegn Nibret, Kasahun Abie, Bayeh Abera   +11 more
doaj   +2 more sources

Bacterial Vaginosis and Its Relation to Caesarean Wound Infection [PDF]

Al-Azhar International Medical Journal, 2022
Background: Bacterial vaginosis (BV) is a common condition among women, with approximately one third of those between 14 and 49 years of age screening positive for BV. A similar proportion of postmenopausal women also screen positive for BV.
Wael Haplas, Ahmed Abdelfattah, Emad Eltemamy Eltemamy, Rafaat Alkady   +3 more
doaj   +1 more source

Causal Graphical Model of Bacterial Vaginosis in Pregnant Women [PDF]

Diseases
Background: This study developed a Causal Graphical Model (CGM) to analyze Bacterial Vaginosis (BV), a condition caused by an imbalance in the vaginal microbiota, whose bacterial composition varies among women.
Maricela García-Avalos, Juana Canul-Reich, Lil María Xibai Rodríguez-Henríquez, Erick Natividad De la Cruz-Hernández   +3 more
doaj   +2 more sources